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The liver contains an acy~glycerol hydro~ase activity 
(liver-lipase) which is releasable by heparin perfusion 
[ 11. Recent work has indicated that this lipase may 
be involved in the cellular uptake of high density lipo- 
protein p~~osp~lolip~ds an  cholesterol from the plasma 
[2,3]. It has been suggested that high density Iipopro- 
tein phospllolip~ds can be hydrolyzed by the enzyme, 
thereby enabling the transfer of high density hpopro- 
t&n cholesterol to the liver [2--41. The question then 
arises whether such a mechanism would be only oper- 
ative in the liver or also in other high density lipopro- 
tein lipid-utilizing organs. Therefore, we studied 
whether the adrenal gland, an organ able to take up 
and utilize high density lipoprotein cholesterol as a 
substrate for steroid hormone synthesis [S-7], also 
contains an enzyme similar to liver-lipase. A neutral 
lipase activity could be extracted from rat adrenals 
by a heparin-containing medium. This activity was 
not influenced by 1 M NaCl and slightly (30%) 
inhibited by serum. The activity was strongly (86%) 
inhibited by an antibody raised against liver-tipase. 
The lipase could be bound to Sepharose---~lepariil and 
eluted by a salt gradient, the pattern of which was 
identical to that of liver-lipase. It is concluded that 
adrenals contain a lipase similar to the heparin-releas- 
able lipase of rat liver. In the adrenals of female rats 
the activity of the lipase (per gram tissue wet weight) 
was equal to the activity found in the livers 
(226 * 14 mU vs 224 * 13 mu, respectively). In rats 
with a corticotrophi~- and prolactin-secreting pituitary 
tumor the activity in the adrenals (per gram wet weight) 
was significantly higher than in the liver (221 “_ 35 mU 
vs 160 f 13 mu). 
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2. ~at~riaIs and methods 
Normandy fed rats were used. The rats were of the 
Wistar strain unless stated otherwise. Adrenals and 
livers were removed from the rats under ether narcosis 
and immediately cooled on ice. Adrenals were trimmed 
of fat and weighed. Homogenates of the adrenals and 
of 50-100 mg liver were made in cold 0.15 M NaCl 
containing 5 IU ~lep~rin~nl~ (Thron~boliquine, Orgarlol~, 
Oss), using a PT 10 Polytron tissue homogenizer (10 s). 
The homogenates were centrifuged in plastic reaction 
vessels in an Eppendorf 3200 centrifuge at 4°C. 
Lipase activities were i?~easured as the release of 
free fatty acids from a glycerol [3H]trioleate emulsion 
stabilized with gum arabic, at pH 8.5, asin [8]. Lipase 
activities are expressed in mU (nmol free fatty acids 
releasedjmin). In the experiments on the pH depen- 
dency of adrenal lipase activity the assays were carried 
out in the same way except that the following buffers 
(0.1 M) were used: sodium acetate pH 4.0,4.5, 5.0; 
sodium phosphate pH 5.8,6.4,6.8; Tris-..HCl pH 8.0, 
8.9; glycine---NaOH pH 9.8 (cf. [9]). 
Antibodies were raised in rabbits against liver- 
lipase purified from ~le~arin-contain~llg rat liver per- 
fusates [lo]. From the antiseru~n the y-globulin frac- 
tion was isolated by precipitation with (N~~~~~SO~ 
and protein A affinity chromatography [2]. The 
y-globulins were taken up in 0.15 M NaCl to 4 mg 
protein/ml (= anti-liver-lipase). 250 ~1 antibody solu- 
tion inhibits 190 mU liver-lipase completely and does 
not affect lipoprotein lipase 121. In control experi- 
ments the y-globulin fraction of an antiserum raised in 
rabbits against non-heparin-releasable monogIyceridase 
from rat liver [ 1 I 1 was used (control y-globulins). 
Female bastard rats (Buffalo X Wag~Rij) of -200 g 
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received a tumor from the corticotrophin/prolactin 
secreting tumor 73 15a into the scapular egion 4 weeks 
before the animals were studied [ 125. 
3. Results 
Homogenates of rat adrenals were found to exhibit 
lipase activities at acid and neutral (alkafine) pH (fig.1). 
After centrifugation of the heparin-containing homog- 
enates almost no lipase activity was found at acid pH, 
while -75% of the neutral lipase activity was recovered 
in the supernatant (fig.1). In 4 different expt 73 + 4% 
(mean + SD) of the total homogenate activity was 
found in the supernatants when measured under stan- 
dard conditions (pH 8.5). The Iipase activity in the 
supernatants was inhibited for 30% by the addition of 
10% fasted rat serum to the assay mixture and not 
affected by 1 M NaCl (table 1). An antibody against 
the lipase, releasable from rat livers by heparin, inhib- 
G--C tot al homogenate 
- supernatant 
Fig.1. pH profile of lipase activity in homogenates and super- 
natants of rat adrenals+ Adrenals of 2 rats were homogenized 
in 4 ml 0.15 M NaCl containing 5 IU heparin/ml. Part of the 
homogenate was sonified for 5 s at 0°C with a Branson 
Sonifier at 2 1 kWz. The other part of the homogenates was 
centrifuged for 5 min at 8000 X g and the supernatant was 
sonified. Lipase activities were measured in duplicate in 
50 ~1 homogenate and supernatant. The data shown represent 
a typical example out of 3 separate xpt. The activities are 
expressed in mU/ml homogenate (o----o) or supernatant 
(*-•)* 
Table I 
Effects of serum and high salt concentration on the neutral 
lipase activity in rat adrenals 
Additions Lipase activity 
(% control) 
.--- --_. ~- 
None 100 
Rat serum, 10% IO f 5 
NaCl, 1.0 M 109 % 8 
i_~ -..-.__ 
The adrenals of 1 rat were homogenized in 2 ml 0.15 M NaCl 
containing 5 U heparin/ml. The homogenate was centrifuged 
for 5 min at 8000 X g. Lipase activity was measured in the 
supernatant in the presence or absence of 10% fasted rat 
serum, with or without 1 .O M NaCl (final cone.). The activity 
measured without additions was taken as 100%. The mean 
values 2 SD of 3 separate xpt are given 
------Sk 
control-x-globulins 
anti-liverlipase 
f 
10 25 
/ul j-globulins 
i 
50 
Fig.2. Inhibition of adrenal ipase by anti-liver-lipase. Adrenal 
homogenates were prepared as under section 2 in heparin- 
containing saline (2 adrenals/4 ml medium) and centrifuged 
for 5 min at 8000 X g. Aliquots (50 ~1) of the supernatants 
were mixed with different amounts of anti-liver-lipase 
(e---o) or control y-globulins (o-o), both containing 
4 mg protein/ml (see section 2). The samples were incubated 
for 5 min at 37°C followed by 30 min at O”C, then lipase 
activities were measured in the samples. The activities were 
expressed as the % of the activities measured without added 
globulins (3.7 * 0.5 mu/ml supernatant = 100%). The lipase 
activity in the supernatant was not affected by preincubation 
in the absence of added y-globulins (not shown). The means 
of 3 separate xpt f SD are given. 
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ited the solubilized lipase activity for 90 ---9S%, while 
control antibodies (raised against non-heparin-releas- 
able rat liver monoglyceridase) had no effect (fig.2). 
The inhibition of the solubilized lipase activity by 
101.11 anti-liver-lipase was determined in a large number 
(IZ = 18) of experiments. The percentage inhibition 
varied from 75-95s (mean t SD 86 + 8). The resid- 
ual activity in the pellet of the homogenates was 
inhibited by the antibody for 56 i 3% (n = 4). 
bearing rats the lipase activity in the adrenals (per 
gram tissue) is significarltly higher than that in the 
liver. The total lipase activity in the adrenals of the 
tun~or-bearing rats is significantly enhanced when com- 
pared to that in the adrenals of control rats, since the 
first are enlarged (hyperplastic) (138 + 35 mg vs 
59 rt 6 mg, means + SD, n = 3). 
The lipase activity of an extract of a defatted 
adrenal preparation could be bound to a Sepharose- 
heparin column. The activity was eluted from the 
column at the same [NaCl] (0.7 M) as the lipase 
activity derived from rat liver (fig.3). These results 
indicate that adrenals contain a lipase activity that 
resembles or may even be identical with the heparin- 
releasable lipase from rat liver. On a tissue wet weight 
base the activities of adrenal- and liver-lipase in female 
rats were found to be equal (table 2). In rats in which 
a corticotro~llil~- and prolactin-producing tumor had 
been induced, the lipase activity in the liver was sig- 
nifica~tly lowered (table 2). Therefore, in the tumor- 
4. Discussion 
After injection of heparin into several species at 
least 2 different lipases are found in the plasma [ 1 ,I 31. 
One of the lipases is lipoprotein lipase (EC 3.1 .I .34). 
The other is an acylglycerol hydrolase that is immu- 
nologically different from lipoprotein Iipase [ 131 L 
This lipase is found in liver, from which it can be 
released by in vitro perfusion with a heparin-contain- 
ing medium [4,14]. This activity has not been found 
in other tissues such as heart, adipose tissue or lung 
[ 131. That the liver is the main source of this post- 
heparin lipase in rats is illustrated by the loss of post- 
heparin serum activity after hepatectomy [ 1 ,131. 
Therefore, this lipase is called liver-, hepatic- or 
hepatic endothelial-lipase [3]. A 
// 
m NaCl 
.* 
adrenal lipass w 
river ,, 00 
Fig.3. Elution of lipase activity of rat adrenals and liver from 
a Sepharose-heparin column by NaCI. The adrenals of 
14 female rats were defatted with acetone and ether. The 
powder (130 mg) was homogenized in 6 ml 10 mM phosphate 
(+5% glycerol) buffer (pH 7.0). The homogenate was centri- 
fuged for 2 min at 8000 X g,. Supernatant (4.9 ml, contain- 
ing 23.4 mU lipase activity) was applied to a Sepharose- 
heparin column (0.9 X 3 cm). The column was washed with 
40 ml phosphate buffer. Then a linear salt gradient (40 ml) 
from O-2 M NaCl was applied to the column. Fractions of 
1 ml were collected and lipase activity determined in 100 ~1 
of the fractions (*---0). The same experiment was carried 
out with 130 mg acetone powder of one of the rat livers used 
(o-o). 
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This paper shows that rat adrenals contain a lipase 
activity different from acid lipase. This neutral Iipase 
is partly inhibited by serum, as was described for liver- 
lipase before [ 151 and not inhibited by I M NaCl and 
therefore is different from lipoprotein lipase. Also the 
Iipase is largely inhibited by an antiserum raised against 
liver-lipase, purified from heparin-containing liver per- 
fusates. It behaves on a Sepharose-heparin column 
identical to Iipase from rat liver. Based on these data 
we conclude that adrenals contain, besides acid lipase, 
a lipase similar to liver-lipase. Preliminary experiments, 
using anti-human liver-lipase and a female human 
adrenal, showed that also in man adrenals may con- 
tain liver-lipase-like activity. The activity per gram 
wet weight was -25% of that observed in rats (52 mU 
vs 226 mu). The contribution of the adrenals to the 
total post-heparin plasma activity will be very low 
because of the relatively low adrenal weight. Still, the 
lipase may exert locally an important action, as the 
activity per gram tissue wet weight is equal in the 
adrenals and in the liver, The function of this lipase 
type in lipid metabolism is not established yet. Injec- 
tion of an antibody against the liver-lipase results in an 
increased serum high density lipoprotein-cholesterol 
level [2,3]. In patients on chronic hemodialysis a 
33 
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negative correlation between high density lipoprotein- 
cholesterol and postheparin plasma liver-lipase activity 
can be shown (L. Verschoor, et al. in preparation). 
FoIlowing oestrogen treatment, liver-lipase is lowered 
[ 161 and high density cholesterol levels are elevated 
[ 171. In women, compared to men, lower lipase 
activities [ 181 and higher density lipoprotein- 
cholesterol concentrations [19] are found. These 
data point to a role of the liver-lipase in the clearing 
of high density lipoprotein-choIestero1. It is possible 
that dependent on the activity of the lipase in situ, 
more or less high density lipoprotein-cholesterol can 
be taken up by the tissue containing this enzyme. In 
this way liver-Iipase (-like) activities in high density 
lipoprotein -cholesterol utilizing organs (liver, adrenals 
and perhaps other steroid hormone producing organs) 
may help to channel high density lipoprotein-cho- 
lesterol to these organs. Such a role of the enzyme 
would be analogous to the directive role of lipoprotein 
lipase in the uptake of serum triglycerides in different 
organs [ZO]. In this respect it is of interest to note that 
under conditions of high ~orticosteroid synthesis (the 
pituitary tumor-bearing rats) the total activity in the 
adrenals is significantly elevated, while that in liver is 
significantly decreased. The relative importance of 
such a system, compared to other regulatory pro- 
cesses [5-71, for the uptake of high density lipopro- 
tein-cholesterol has to be established. 
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